Histidine to alanine mutants of human dihydroorotate dehydrogenase
- 1 August 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (4) , 459-465
- https://doi.org/10.1016/s0006-2952(97)00197-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Immunosuppressive Metabolite of Leflunomide Is a Potent Inhibitor of Human Dihydroorotate DehydrogenaseBiochemistry, 1996
- Recombinant Human Dihydroorotate Dehydrogenase: Expression, Purification, and Characterization of a Catalytically Functional Truncated EnzymeArchives of Biochemistry and Biophysics, 1995
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomideBiochemical Pharmacology, 1995
- LEFLUNOMIDE CONTROLS REJECTION IN HAMSTER TO RAT CARDIAC XENOGRAFTSTransplantation, 1994
- LEFLUNOMIDE IN EXPERIMENTAL TRANSPLANTATIONTransplantation, 1994
- The Development of Brequinar as an Immunosuppressive Drug for TransplantationImmunological Reviews, 1993
- Cloning and sequencing of a human cDNA coding for dihydroorotate dehydrogenase by complementation of the corresponding yeast mutantGene, 1992
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- [9] Dihydroorotate dehydrogenase (Neurospora)Published by Elsevier ,1978